JPS58170796A - 架橋コラーゲンの水性組成物とその調製方法 - Google Patents
架橋コラーゲンの水性組成物とその調製方法Info
- Publication number
- JPS58170796A JPS58170796A JP58038117A JP3811783A JPS58170796A JP S58170796 A JPS58170796 A JP S58170796A JP 58038117 A JP58038117 A JP 58038117A JP 3811783 A JP3811783 A JP 3811783A JP S58170796 A JPS58170796 A JP S58170796A
- Authority
- JP
- Japan
- Prior art keywords
- collagen
- glutaraldehyde
- crosslinking agent
- crosslinking
- atelopeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000008186 Collagen Human genes 0.000 title claims description 89
- 108010035532 Collagen Proteins 0.000 title claims description 89
- 229920001436 collagen Polymers 0.000 title claims description 88
- 238000002360 preparation method Methods 0.000 title claims description 28
- 239000000126 substance Substances 0.000 title description 3
- 238000002054 transplantation Methods 0.000 title description 2
- 239000007943 implant Substances 0.000 claims description 24
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical group O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 20
- 238000004132 cross linking Methods 0.000 claims description 20
- 239000003431 cross linking reagent Substances 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 13
- 238000010791 quenching Methods 0.000 claims description 13
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- 230000000171 quenching effect Effects 0.000 claims description 12
- 150000001299 aldehydes Chemical class 0.000 claims description 10
- 239000012530 fluid Substances 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 9
- 239000000501 collagen implant Substances 0.000 claims description 7
- 239000011541 reaction mixture Substances 0.000 claims description 6
- 239000004971 Cross linker Substances 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 230000003416 augmentation Effects 0.000 claims description 5
- 210000004872 soft tissue Anatomy 0.000 claims description 5
- 230000002378 acidificating effect Effects 0.000 claims description 4
- 239000012736 aqueous medium Substances 0.000 claims description 3
- 210000004207 dermis Anatomy 0.000 claims description 3
- 230000003472 neutralizing effect Effects 0.000 claims description 3
- 239000007900 aqueous suspension Substances 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 230000001256 tonic effect Effects 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- 239000000243 solution Substances 0.000 description 22
- 239000000203 mixture Substances 0.000 description 16
- 238000009472 formulation Methods 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 10
- 229940088598 enzyme Drugs 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 210000003491 skin Anatomy 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 6
- 239000006185 dispersion Substances 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 241000283690 Bos taurus Species 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 230000007547 defect Effects 0.000 description 4
- 230000007928 solubilization Effects 0.000 description 4
- 238000005063 solubilization Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 108090000284 Pepsin A Proteins 0.000 description 3
- 102000057297 Pepsin A Human genes 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 102000013373 fibrillar collagen Human genes 0.000 description 3
- 108060002894 fibrillar collagen Proteins 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 229940111202 pepsin Drugs 0.000 description 3
- 230000002688 persistence Effects 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 206010040954 Skin wrinkling Diseases 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 229960003767 alanine Drugs 0.000 description 2
- 230000003190 augmentative effect Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 238000010562 histological examination Methods 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000003589 local anesthetic agent Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 229960001322 trypsin Drugs 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- XINQFOMFQFGGCQ-UHFFFAOYSA-L (2-dodecoxy-2-oxoethyl)-[6-[(2-dodecoxy-2-oxoethyl)-dimethylazaniumyl]hexyl]-dimethylazanium;dichloride Chemical compound [Cl-].[Cl-].CCCCCCCCCCCCOC(=O)C[N+](C)(C)CCCCCC[N+](C)(C)CC(=O)OCCCCCCCCCCCC XINQFOMFQFGGCQ-UHFFFAOYSA-L 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 101100283604 Caenorhabditis elegans pigk-1 gene Proteins 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 206010009269 Cleft palate Diseases 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 229920002085 Dialdehyde starch Polymers 0.000 description 1
- 208000006926 Discoid Lupus Erythematosus Diseases 0.000 description 1
- 208000002325 Funnel Chest Diseases 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010067994 Mucosal atrophy Diseases 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 206010034204 Pectus excavatum Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010039710 Scleroderma Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000005248 Vocal Cord Paralysis Diseases 0.000 description 1
- RXHSGRQJJBSBPN-UHFFFAOYSA-L [Na+].[Na+].Cl.OP([O-])([O-])=O Chemical compound [Na+].[Na+].Cl.OP([O-])([O-])=O RXHSGRQJJBSBPN-UHFFFAOYSA-L 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 239000000512 collagen gel Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000004921 cutaneous lupus erythematosus Diseases 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000003237 epithelioid cell Anatomy 0.000 description 1
- 239000013020 final formulation Substances 0.000 description 1
- 125000000267 glycino group Chemical group [H]N([*])C([H])([H])C(=O)O[H] 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 210000001724 microfibril Anatomy 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 210000002976 pectoralis muscle Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012475 sodium chloride buffer Substances 0.000 description 1
- 208000013637 submucosal cleft palate Diseases 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35587982A | 1982-03-08 | 1982-03-08 | |
| US355879 | 1982-03-08 | ||
| US375665 | 1982-05-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58170796A true JPS58170796A (ja) | 1983-10-07 |
| JPH0136840B2 JPH0136840B2 (enrdf_load_stackoverflow) | 1989-08-02 |
Family
ID=23399193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58038117A Granted JPS58170796A (ja) | 1982-03-08 | 1983-03-08 | 架橋コラーゲンの水性組成物とその調製方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS58170796A (enrdf_load_stackoverflow) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5137875A (en) * | 1988-04-19 | 1992-08-11 | Shiseido Co., Ltd. | Hyaluronic acid-containing aqueous solution or aqueous dispersion of collagen |
| WO1998054224A1 (fr) * | 1997-05-28 | 1998-12-03 | Tapic International Co., Ltd. | Gel au collagene |
| JP2006513132A (ja) * | 2002-05-21 | 2006-04-20 | コルテク オーストラリア リミテッド | コラーゲンおよびコラーゲンを製造する方法 |
| JP2007296401A (ja) * | 1995-06-07 | 2007-11-15 | Angiotech Biomaterials Corp | 生体適合性の粘着剤組成物 |
-
1983
- 1983-03-08 JP JP58038117A patent/JPS58170796A/ja active Granted
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5137875A (en) * | 1988-04-19 | 1992-08-11 | Shiseido Co., Ltd. | Hyaluronic acid-containing aqueous solution or aqueous dispersion of collagen |
| JP2007296401A (ja) * | 1995-06-07 | 2007-11-15 | Angiotech Biomaterials Corp | 生体適合性の粘着剤組成物 |
| WO1998054224A1 (fr) * | 1997-05-28 | 1998-12-03 | Tapic International Co., Ltd. | Gel au collagene |
| JP2006513132A (ja) * | 2002-05-21 | 2006-04-20 | コルテク オーストラリア リミテッド | コラーゲンおよびコラーゲンを製造する方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0136840B2 (enrdf_load_stackoverflow) | 1989-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0083868B1 (en) | Collagen implant material for augmenting soft tissue | |
| US4582640A (en) | Injectable cross-linked collagen implant material | |
| EP0376931B1 (en) | Process for making collagen membranous materials for medical use | |
| CA1279010C (en) | Collagen compositions for bone repair containing autogeneic marrow | |
| US4776890A (en) | Preparation of collagen hydroxyapatite matrix for bone repair | |
| EP0089145B1 (en) | Injectable cross-linked collagen implant material | |
| US5137875A (en) | Hyaluronic acid-containing aqueous solution or aqueous dispersion of collagen | |
| US4314380A (en) | Artificial bone | |
| US4268131A (en) | Fiber collagen contact lens | |
| US4440750A (en) | Osteogenic composition and method | |
| CA2343806C (en) | Collagenous tissue compositions | |
| EP0419111B1 (en) | Collagen compositions and methods for preparation thereof | |
| US4505855A (en) | Transparent non-fibrilized collagen material by ultracentrifugation | |
| US5658593A (en) | Injectable compositions containing collagen microcapsules | |
| CN114085394B (zh) | 一种重组胶原蛋白双相凝胶及其制备方法和应用 | |
| AU3665693A (en) | High concentration homogenized collagen compositions | |
| US5138030A (en) | Process for extracting type I collagen form an avian source, and applications therefor | |
| JPH0712375B2 (ja) | 移植組成物及びその製造方法 | |
| JPS58170796A (ja) | 架橋コラーゲンの水性組成物とその調製方法 | |
| AU2004237992B2 (en) | Insoluble globin injectable implant | |
| RU2433828C1 (ru) | Инъекционный гетерогенный биополимерный гидрогель для заместительной и регенеративной хирургии и способ его получения | |
| CN119656385B (zh) | 一种注射用复配胶原蛋白填充剂的制备方法 | |
| CA1255589A (en) | Injectable cross-linked collagen implant material |